Literature DB >> 19563998

Provocation tests in drug hypersensitivity.

Werner Aberer1, Birger Kränke.   

Abstract

Provocation tests are regarded as the "gold standard" to establish or exclude the presence of hypersensitivity to a certain drugs because they reproduce not only allergy symptoms but other adverse manifestations, irrespective of their pathomechanism. Provocation testing is potentially harmful and should be considered only after balancing the risk-benefit ratio in the individual patient. The reasons for false-positive and false-negative results are numerous, including loss of sensitization, cofactors not being included in the diagnostic procedure, and the potential induction of tolerance during provocation. When conducted by experienced clinicians in a carefully monitored setting, however, drug provocation testing is a safe method to confirm or exclude drug hypersensitivity.

Entities:  

Mesh:

Year:  2009        PMID: 19563998     DOI: 10.1016/j.iac.2009.04.008

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  9 in total

Review 1.  Peri-operative anaphylaxis.

Authors:  Linda Nel; Efrem Eren
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

2.  Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.

Authors:  Marek L Kowalski; Ignacio Ansotegui; Werner Aberer; Mona Al-Ahmad; Mubeccel Akdis; Barbara K Ballmer-Weber; Kirsten Beyer; Miguel Blanca; Simon Brown; Chaweewan Bunnag; Arnaldo Capriles Hulett; Mariana Castells; Hiok Hee Chng; Frederic De Blay; Motohiro Ebisawa; Stanley Fineman; David B K Golden; Tari Haahtela; Michael Kaliner; Connie Katelaris; Bee Wah Lee; Joanna Makowska; Ulrich Muller; Joaquim Mullol; John Oppenheimer; Hae-Sim Park; James Parkerson; Giovanni Passalacqua; Ruby Pawankar; Harald Renz; Franziska Rueff; Mario Sanchez-Borges; Joaquin Sastre; Glenis Scadding; Scott Sicherer; Pongsakorn Tantilipikorn; James Tracy; Vera van Kempen; Barbara Bohle; G Walter Canonica; Luis Caraballo; Maximiliano Gomez; Komei Ito; Erika Jensen-Jarolim; Mark Larche; Giovanni Melioli; Lars K Poulsen; Rudolf Valenta; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2016-10-12       Impact factor: 4.084

3.  [Clinical practise guideline of the special interest group in allergy of the ÖGDV - Drug provocation testing in the diagnosis of cutaneous drug reactions].

Authors:  Birger Kränke; Werner Aberer; Cornelia Egger; Thomas Hawranek; Norbert Reider; Beatrix Volc-Platzer; Stefan Wöhrl
Journal:  Wien Klin Wochenschr       Date:  2011-09-02       Impact factor: 1.704

4.  Drug allergy.

Authors:  Richard Warrington; Fanny Silviu-Dan
Journal:  Allergy Asthma Clin Immunol       Date:  2011-11-10       Impact factor: 3.406

5.  Identifying drug allergies by means of exposure testing - the frequency and nature of hypersensitivity reactions.

Authors:  Tobias Welponer; Matthias Brandlmaier; Bernd Feuerstein; Johann W Bauer
Journal:  Postepy Dermatol Alergol       Date:  2021-11-01       Impact factor: 1.664

6.  Drug provocation tests: up-date and novel approaches.

Authors:  Anca Mirela Chiriac; Pascal Demoly
Journal:  Allergy Asthma Clin Immunol       Date:  2013-04-03       Impact factor: 3.406

7.  A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity.

Authors:  Bernard Yu-Hor Thong; Rita Mirakian; Mariana Castells; Werner Pichler; Antonino Romano; Patrizia Bonadonna; Deleanu Diana; Marek Kowalski; Anahi Yanez; Ramon Lleonart; Mario Sanchez-Borges; Pascal Demoly
Journal:  World Allergy Organ J       Date:  2011-12-14       Impact factor: 4.084

Review 8.  Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management.

Authors:  Evy Yunihastuti; Alvina Widhani; Teguh Harjono Karjadi
Journal:  Asia Pac Allergy       Date:  2014-01-31

Review 9.  Drug allergy.

Authors:  Richard Warrington; Fanny Silviu-Dan; Tiffany Wong
Journal:  Allergy Asthma Clin Immunol       Date:  2018-09-12       Impact factor: 3.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.